Placeholder text

Botulinum Toxin for Urinary Tract Disease

Botulinum Toxin for Urinary Tract Disease Medicine

Botulinum Toxin for Urinary Tract Disease

0 - Default Title
Description
Botulinum toxin was approved by the Food and Drug Administration in 2011 for neurogenic bladder and in 2013 for idiopathic overactive bladder (OAB). In this Special Issue, we address the question of where we stand with this therapy a decade later. Has it prevailed and been proven useful? Which techniques have become established, and how were they optimized? Are more practical ways of distribution on the way? What acceptance problems or obstacles to long-term use might exist among patients or doctors? What are the risks? Has the therapy gained a foothold in the outpatient sector?
Product details
Number of Pages:
138
Release Date:
2026-01-23
Publication Date:
2026-01-23
Publisher:
MDPI AG
Languages:
Original: English
ISBN10:
3725863385
ISBN13:
9783725863389
Weight:
545 g
Height:
175 cm
Width:
250 cm
Thickness:
14 cm
Currently sold out